Ambry Genetics reports results from clinical diagnostic exome™ testing of three patients.
Ambry Genetics is approved by Medicare. Collection is based on published Medicare prevailing rates for locality 26/31146. Front and back copy of insurance card and insurance authorization must be included.
A completed Advance Beneficiary Notice (ABN) is required for Medicare patients.
Ambry Genetics is a participating provider in the following states: